Intemed: International Journal of Research in Integrated Medical Sciences (IJ-RIMS) Open Access | Peer-Reviewed | Integrated Medical Sciences
International Journal
  • ISSN: 3139-0935(Online)
  • Email: shriramragad1992@gmail.com
  • Contact: +91 7387468519
  • Publisher: Shri Dhanvantari International Publication
Open Access, Peer-Reviewed Journal for Research in Integrated Medical Sciences.
Raheri Bk, Sindkhed Raja, Buldhana | Maharashtra, India

Article Details

  1. Home
  2. Articles
Back to articles

THERAPEUTIC EFFECT OF NIMBA CHOORNA IN PRAMEHA: A SINGLE-CASE STUDY WITH REFERENCE TO TYPE 2 DIABETES MELLITUS

Abstract

Prameha is described in Ayurveda as a disorder involving abnormal urinary quantity and quality and is closely relevant to the clinical spectrum of metabolic disease. Contemporary Type 2 diabetes mellitus is characterized by persistent hyperglycaemia and is strongly influenced by dietary and lifestyle factors. Nimba (Azadirachta indica) possesses traditionally described Tikta-Kashaya Rasa, Laghu-Ruksha Guna and Kapha- Pitta-shamaka activity, with pharmacological literature also describing hypoglycaemic, antioxidant and anti- inflammatory effects. Aim: To document the clinical response to Nimba Choorna in a patient presenting with features of Prameha and biochemical findings compatible with Type 2 diabetes mellitus Materials and Methods: A 45-year-old female attending the Kayachikitsa OPD at College of Ayurveda and Research Centre, Nigdi, Pune, presented with increased frequency of urination, nocturnal urination, weakness and increased appetite. Baseline fasting and postprandial blood glucose were 169.2 mg/dL and 242.5 mg/dL, respectively. Nimba Choorna was administered orally at 3 g twice daily before meals for 45 days. Symptoms were documented at baseline and during follow-up, while biochemical parameters were reassessed. Observation and Result: Progressive improvement was recorded in the assessed subjective symptoms. Fasting blood glucose decreased to 141.7 mg/dL and postprandial blood glucose to 164.3 mg/dL on the documented 30th-day assessment. Urine sugar remained negative. By day 45, the patient reported marked reduction in the presenting complaints. Conclusion: The present uncontrolled single-case observation indicates a favourable symptomatic and biochemical change following Nimba Choorna administration. Because the observation represents one patient without a comparator, it should be regarded as preliminary and hypothesis-generating rather than proof of efficacy.

Keywords
PramehaNimba ChoornaType 2 Diabetes MellitusPrabhuta MutrataNaktamutrataDaurbalya